Aggressive B cell lymphomas of the gastrointestinal tract: Clinicopathologic and genetic analysis

Virchows Archiv

Volumn 459, Issue 5, 2011, Pages 495-502

  Choi, Song Yi ^a   Kim, Seok Jin ^b   Kim, Won Seog ^b   Kim, Kihyun ^b   Ko, Young Hyeh ^b  

^a Chungbuk National University Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Burkitt lymphoma; c MYC; Diffuse large B cell lymphoma; Gray zone lymphoma; Intermediate lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE PROBE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LARGE CELL LYMPHOMA; MALE; ONCOGENE C MYC; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE REARRANGEMENT; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED;

EID: 80855133520     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1153-3     Document Type: Article

References (22)

1. LM Boxer CV Dang 2001 Translocations involving c-myc and c-myc function Oncogene 20 5595 5610 11607812 10.1038/sj.onc.1204595 1:CAS:528: DC%2BD3MXnt12gtLk%3D (Pubitemid 32928100)
2. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM (2008) Burkitt lymphoma. In: Steven H, Swerdlow EC, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 265-266
3. S Barrans S Crouch A Smith K Turner R Owen R Patmore E Roman A Jack 2010 Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab J Clin Oncol 28 3360 3365 20498406 10.1200/JCO.2009.26.3947 1:CAS:528:DC%2BC3cXhtVajurvL
4. N Niitsu M Okamoto I Miura M Hirano 2009 Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations Leukemia 23 777 783 19151788 10.1038/leu.2008.344 1:CAS:528:DC%2BD1MXks1Sitbg%3D
5. Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Steven H, Swerdlow EC, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 265-266
6. Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop. doi: 10.1007/s12308-009-0039- 7
7. GW Slack RD Gascoyne 2011 MYC and aggressive B-cell lymphomas Adv Anat Pathol 18 219 228 21490439 10.1097/PAP.0b013e3182169948
8. RF McClure ED Remstein WR Macon GW Dewald TM Habermann A Hoering PJ Kurtin 2005 Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior Am J Surg Pathol 29 1652 1660 16327438 10.1097/01.pas.0000180442.87022.08
9. E Haralambieva EJ Boerma GW van Imhoff S Rosati E Schuuring HK Muller-Hermelink PM Kluin G Ott 2005 Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma Am J Surg Pathol 29 1086 1094 16006805 (Pubitemid 41045555)
10. M Hummel S Bentink H Berger W Klapper S Wessendorf TF Barth HW Bernd SB Cogliatti J Dierlamm AC Feller ML Hansmann E Haralambieva L Harder D Hasenclever M Kuhn D Lenze P Lichter JI Martin-Subero P Moller HK Muller-Hermelink G Ott RM Parwaresch C Pott A Rosenwald M Rosolowski C Schwaenen B Sturzenhofecker M Szczepanowski H Trautmann HH Wacker R Spang M Loeffler L Trumper H Stein R Siebert 2006 A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling N Engl J Med 354 2419 2430 16760442 10.1056/NEJMoa055351 1:CAS:528:DC%2BD28XlsVajur0%3D (Pubitemid 43855045)
11. NA Johnson KJ Savage O Ludkovski S Ben-Neriah R Woods C Steidl MJ Dyer R Siebert J Kuruvilla R Klasa JM Connors RD Gascoyne DE Horsman 2009 Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival Blood 114 2273 2279 19597184 10.1182/blood-2009-03-212191 1:CAS:528:DC%2BD1MXhtFOgtrfJ
12. M Snuderl OK Kolman YB Chen JJ Hsu AM Ackerman PD Cin JA Ferry NL Harris RP Hasserjian LR Zukerberg JS Abramson EP Hochberg H Lee AI Lee CE Toomey AR Sohani 2010 B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma Am J Surg Pathol 34 327 340 20118770 10.1097/PAS.0b013e3181cd3aeb
13. N Macpherson D Lesack R Klasa D Horsman JM Connors M Barnett RD Gascoyne 1999 Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation J Clin Oncol 17 1558 1567 10334544 1:STN:280:DyaK1M3msFOisQ%3D%3D
14. JH van Krieken M Raffeld S Raghoebier ES Jaffe GJ van Ommen PM Kluin 1990 Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas Blood 76 797 800 2200538 (Pubitemid 20253296)
15. JH Van Krieken LJ Medeiros ST Pals M Raffeld PM Kluin 1992 Diffuse aggressive B-cell lymphomas of the gastrointestinal tract. An immunophenotypic and gene rearrangement analysis of 22 cases Am J Clin Pathol 97 170 178 1546685
16. S Raghoebier MH Kramer JH van Krieken D de Jong J Limpens JC Kluin-Nelemans GJ van Ommen PM Kluin 1991 Essential differences in oncogene involvement betweenprimary nodal and extranodal large cell lymphoma Blood 78 2680 2685 1824261 1:STN:280:DyaK38zpvFOmsg%3D%3D
17. MH Kramer J Hermans E Wijburg K Philippo E Geelen JH van Krieken D de Jong E Maartense E Schuuring PM Kluin 1998 Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma Blood 92 3152 3162 9787151 1:CAS:528:DyaK1cXntFCqsLY%3D (Pubitemid 28492322)
18. SB Cogliatti U Novak S Henz U Schmid P Moller TF Barth 2006 Diagnosis of Burkitt lymphoma in due time: a practical approach Br J Haematol 134 294 301 16848772 10.1111/j.1365-2141.2006.06194.x 1:CAS:528:DC%2BD28XosFCju7c%3D (Pubitemid 43990790)
19. A Kanungo LJ Medeiros LV Abruzzo P Lin 2006 Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis Mod Pathol 19 25 33 16258503 10.1038/modpathol.3800500 1:CAS:528:DC%2BD2MXhtlSqu7zI (Pubitemid 43250976)
20. C Bellan L Stefano F de Giulia EA Rogena L Lorenzo 2009 Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach Hematol Oncol 27 182 185 19670467 10.1002/hon.914
21. S Nakamura H Ye CM Bacon A Goatly H Liu L Kerr AH Banham B Streubel T Yao M Tsuneyoshi A Savio M Takeshita P Dartigues A Ruskoné-Fourmestraux T Matsumoto M Iida MQ Du 2008 Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma Clin Cancer Res 14 3002 3010 18445693 10.1158/1078-0432.CCR-07-4946 1:CAS:528:DC%2BD1cXmtVCmtLk%3D
22. KJ Savage NA Johnson S Ben-Neriah JM Connors LH Sehn P Farinha DE Horsman RD Gascoyne 2009 MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy Blood 114 3533 3537 19704118 10.1182/blood-2009-05-220095 1:CAS:528: DC%2BD1MXhtlyjsr3E